Abstract
Study of brain tumors (BT) has revealed the importance of cognitive and behavioral assessment to clinical care and prognosis. This paper overviews recent literature, focusing on the main points of interest and current methods, providing recommendations for advancing research. Histological aspects, disease progression, treatment-related neurotoxicity, and co-morbidities determine the cognitive patterns of BT. Mental slowing with prominent executive and memory compromise usually mark the advanced phases of disease, whereas normal cognitive performance or subtle behavioral symptoms characterize the early disease course, irrespective of tumor location. Neurocognitive assessment may indicate brain damage in otherwise neurologically normal patients, explain pathological behavior, and provide reliable measures of outcome, contributing to improving the management of patients. Scarce attention has been devoted to social cognitive deficits which are expected to impair autonomy and relationships. Interest in non-pharmacological treatment of cognitive impairment is a growing area although methodological difficulties persist. Homogeneous patient populations, longitudinal study designs including baseline evaluations, and measurement of the lowest and highest levels of cognitive performance seem indispensable to advancing the study of the cognitive and behavioral changes provoked by BT. Future investigations are also expected to clarify the clinical significance of such changes, their effect on quality of life, and the efficacy of specific rehabilitation treatments.
Similar content being viewed by others
References
Keime-Guibert F, Chinot O, Taillandier L, Cartalat-Carel S, Frenay M, Kantor G, Guillamo JS, Jadaud E, Colin P, Bondiau PY, Meneï P, Loiseau H, Bernier V, Honnorat J, Barrié M, Mokhtari K, Mazeron JJ, Bissery A, Delattre JY (2007) Radiotherapy for glioblastoma in the elderly. New Engl J Med 356:1527–1535
Hottinger AF, Yoon H, Deangelis LM, Abrey LE (2009) Neurological outcome of long-term glioblastoma survivors. J Neurooncol 95:301–305
Bosma I, Vos MJ, Heimans JJ, Taphoorn MJ, Aaronson NK, Postma TJ, van der Ploeg HM, Muller M, Vandertop WP, Slotman BJ (2007) The course of neurocognitive functioning in high-grade glioma patients. J Neurooncol 9:53–62
Hahn CA, Dunn RH, Logue PE, King JH, Edwards CL, Alperin EC (2003) Prospective study of neuropsychologic testing and quality-of-life assessment of adults with primary malignant brain tumors. Int J Radiat Oncol Biol Phys 55:992–999
Crossen JR, Garwood D, Glatstein E, Newvelt EA (1994) Neurobehavioral sequalae of cranial irradiation in adults: a review of radiation-induced encephalopathy. J Clin Oncol 12:627–642
Douw L, Klein M, van den Fagel SS, Heuvel J, Taphoorn MJ, Aaronson NK, Postma TJ, Vandertop WP, Mooij JJ, Boerman RH, Beute GN, Sluimer JD, Slotman BJ, Reijneveld JC, Heimans JJ (2009) Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol 8:810–818
Giovagnoli AR, Boiardi A (1994) Cognitive impairment and quality of life in long-term survivors of malignant brain tumors. Ital J Neurol Sci 15(9):481–488
Taphoorn MJ, Klein M (2004) Cognitive deficits in adult patients with brain tumors. Lancet Neurol 66:159–168
Douw L, van Dellen E, de Groot M, Heimans JJ, Klein M, Stam CJ, Reijneveld JC (2010) Epilepsy is related to theta band brain connectivity and network topology in brain tumor patients. BMC Neurosci 11:103. doi:10.1186/1471-2202-11-103
Kahana MJ (2006) The cognitive correlates of human brain oscillations. J Neurosci 26(6):1669–1672
Giovagnoli AR, Casazza M, Ciceri E, Avanzini G (2006) Preserved memory in temporal lobe epilepsy patients after surgery for low-grade tumour. A pilot study. Neurol Sci 28:171–174
Klein M, Engelberts NH, van der Ploeg HM, Kasteleijn-Nolst Trenité DG, Aaronson NK, Taphoorn MJ, Baaijen H, Vandertop WP, Muller M, Postma TJ, Heimans JJ (2003) Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 54:514–520
Tucha O, Smely C, Preier M, Lange KW (2000) Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 47:324–333
Olson JD, Riedel E, DeAngelis LM (2000) Long-term outcome of low-grade oligodendroglioma and mixed glioma. Neurology 54:1442–1448
Taphoorn MJB, Klein Schiphorst A, Snoek FJ, Lindeboom J, Wolbers JG, Karim ABMF, Huijgens PC, Heimans JJ (1994) Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy. Ann Neurol 36:48–54
Klein M, Heimans JJ, Aaronson NK. van der Ploeg HM, Grit J, Muller M, Postma TJ, Mooij JJ, Boerman RH, Beute GN, Ossenkoppele GJ, van Imhoff GW, Dekker AW, Jolles J, Slotman BJ, Struikmans H, Taphoorn MJ (2002) Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low grade gliomas: a comparative study. Lancet 360:1361–1368
Laack NN, Brown PD, Ivnik RJ, Furth AF, Ballman KV, Hammack JE, Arusell RM, Shaw EG, Buckner JC, North Central Cancer Treatment Group (2005) Cognitive function after radiotherapy for supratentorial low-grade gliomas: a north central cancer treatment group prospective study. Int J Radiat Oncol Biol Phys 63:1175–1183
Brown PD, Buckner JC, O’Fallon JR, Iturria NL, Brown CA, O’Neill BP, Scheithauer BW, Dinapoli RP, Arusell RM, Curran WJ, Abrams R, Shaw EG (2003) Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination. J Clin Oncol 21:2519–2524
Duffau H, Capelle I, Denvil D, Sichez N, Gatignol P, Lopes M, Mitchell MC, Sichez JP, Van Effenterre R (2003) Functional recovery after surgical resection of low-grade gliomas in eloquent brain: hypothesis of brain compensation. J Neurol Neurosurg Psychiatry 74:901–907
Gregor A, Cull A, Traynor E, Stewart M, Lander F, Love S (1996) Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters. Radiother Oncol 41:55–59
Imperato JP, Paleologos NA, Vick NA (1990) Effects of treatment on long-term survivors with malignant gliomas. Ann Neurol 28:818–922
Kleinberg L, Wallner K, Malkin MG (1993) Good performance status of long-term disease-free survivors of intracranial gliomas. Int J Radiat Oncol Biol Phys 26:129–133
Scheibel RS, Meyers CA, Levin VA (1996) Cognitive dysfunction following surgery for intracerebral glioma: influence of histopathology, lesion location, and treatment. J Neurooncol 30:61–69
Steinbach JP, Blaicher HP, Herrlinger U, Wick W, Nagele T, Meyermann R, Tatagiba M, Bamberg M, Dichgans J, Karnath HO, Weller M (2006) Surviving glioblastoma for more than 5 years: the patient’s perspective. Neurology 66(2):239–242
Corn BW, Wang M, Fox S, Michalski J, Purdy J, Simpson J, Kresl J, Curran WJ Jr, Diaz A, Mehta M, Movsas B (2009) Health related quality of life and cognitive status in patients with glioblastoma multiforme receiving escalating doses of conformal three dimensional radiation on RTOG 98-03. J Neurooncol 95:247–257
Brown PD, Jensen AW, Felten SJ, Ballman KV, Schaefer PL, Jaeckle KA, Cerhan JH, Buckner JC (2006) Detrimental effects of tumor progression on cognitive function of patients with high-grade glioma. J Clin Oncol 24:5427–5433
Armstrong CL, Goldstein B, Shera D, Ledakis GE, Tallent EM (2003) The predictive value of longitudinal neuropsychological assessment in the early detection of brain tumor recurrence. Cancer 97:649–656
Bosma I, Vos M, Heimans JJ, Taphoorn MJ, Aaronson NK, Postma TJ, van der Ploeg HM, Muller M, Vandertop WP, Slotman BJ, Klein M (2007) The course of neurocognitive status in high-grade glioma patients. Neuro-Oncol 9:53–62
Meyers CA, Hess KR, Yung WK, Levin VA (2000) Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 18:646–650
Herman MA, Tremont-Luktas I, Meyers CA, Trask DD, Froseth C, Renschler MF, Mehta MPJ (2003) Neurocognitive and functional assessment of patients with brain metastases. Am J Clin Oncol 26:273–279
Meyers CA, Smith JA, Bezjak A, Mehta MP, Liebmann J, Illidge T, Kunkler I, Caudrelier JM, Eisenberg PD, Meerwaldt J, Siemers R, Carrie C, Gaspar LE, Curran W, Phan SC, Miller RA, Renschler MF (2004) Neurocognitive function and progression in patients with brain metastases treated with whole-brain radiation and motexafin gadolinium: results of a randomized phase III trial. J Clin Oncol 22:157–165
Correa DD, De Angelis LM, Shi W, Thaler H, Glass A, Abrey LE (2004) Cognitive functions in survivors of primary central nervous system lymphoma. Neurology 62:547–548
Harder H, Holtel H, Bromberg JEC, Poortmans P, Haaxma-Reiche H, Kluin-Nelemans HC, Menten J, van den Bent MJ (2004) Cognitive status and quality of life for primary CNS lymphoma. Neurology 62:544–547
Correa DD, Rocco-Donovan M, De Angelis LM, Dolgoff-Kaspar R, Iwamoto F, Yahalom J, Abrey LE (2009) Prospective cognitive follow-up in primary CNS lymphoma patients treated with chemotherapy and reduced-dose radiotherapy. J Neurooncol 91:315–321
Teixidor P, Gatignol P, Leroy M, Masuet-Aumatell C, Capelle L, Duffau H (2007) Assessment of verbal working memory before and after surgery for low-grade glioma. J Neurooncol 81:305–313
Duffau H (2009) Surgery of low-grade gliomas: towards a functional neurooncology. Curr Opin Oncol 21:249–543
Talacchi A, Santini B, Savazzi S, Gerosa M (2010) Cognitive effects of tumour and surgical treatment in glioma patients. J Neurooncol 103:541–549
Scheibel RS, Valentine AD, O’Brien S, Meyers CA (2004) Cognitive dysfunction and depression during treatment with interferon-alpha and chemotherapy. J Neuropsychiatry Clin Neurosci 16:185–191
Wen PY (2003) Central nervous system complications of cancer therapy. In: Shiff D, Wen PY (eds) Cancer neurology in clinical practice. Humana Press, Totowa, pp 215–231
Giovagnoli AR, Franceschetti S, Reati F, Parente A, Maccagnano C, Villani F, Spreafico R (2011) Theory of mind in frontal and temporal lobe epilepsy: cognitive and neural aspects. Epilepsia 52:1995–2002
Anderson SW, Damasio H, Tranel D (1990) Neuropsychological impairments associated with lesion caused by tumor or stroke. Arch Neurol 47:397–405
Cappa SF, Cipollotti L (2008) Cognitive and behavioural disorders associated with space occupying lesions. In: Cappa SF, Abutalebi J, Demonet J-F, Fletcher PC, Garrard P (eds) Cognitive neurolgoy. A clinical textbook. Oxford University Press, New York, pp 161–182
Costello A, Shallice T, Gullan R, Beany R (2004) The early effects of radiotherapy on intellectual and cognitive functioning in patients with frontal brain tumors: the use of a new neuropsychological methodology. J Neurooncol 67:351–359
Yoshii Y, Tominaga D, Sugimoto K, Tsuchida Y, Hyodo A, Yonaha H, Kushi S (2008) Cognitive function of patients with brain tumor in pre- and postoperative stage. Surg Neurol 69:51–61
Jones-Gotman M, Smith ML, Risse GL, Westerveld M, Swanson SJ, Giovagnoli AR, Lee T, Mader-Joaquim MJ, Piazzini A (2010) The contribution of neuropsychology to diagnostic assessment in epilepsy. Epilepsy Behav 18:3–12
Giovagnoli AR, Silvani A, Colombo E, Boiardi A (2005) Facets and determinants of quality of life in recurrent high-grade glioma patients. J Neurol Neurosurg Psychiatry 76:562–568
Meyers CA, Hess KR (2003) Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro-Oncology 5:89–95
Vigliani M-A, Sichez N, Poisson M, Delattre J-Y (1996) A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results. Int J Radiat Oncol Biol Phys 35:527–533
Fliessbach K, Rogowski S, Hoppe C, Sabel M, Goeppert M, Helmstaedter C, Calabrese P, Schackert G, Tonn J-C, Simon M (2010) Computer-based assessment of cognitive functions in brain tumor patients. J Neurooncol 100:427–437
Shaw P, Lawrence EJ, Radbourne C, Bramham J, Polkey CE, David AS (2004) The impact of early and late damage to the human amygdala on “theory of mind” reasoning. Brain 127:1535–1548
Shaw P, Lawrence E, Bramaham J, Brierley B, Radbourne C, David AS (2007) A prospective study of the effects of anterior temporal lobectomy on emotion recognition and theory of mind. Neuropsychologia 45:2783–2790
Gallagher HL, Happé F, Brunswick N, Fletcher PC, Frith U, Frith CD (2000) Reading the mind in cartoons and stories: an fMRI study of “theory of mind” in verbal and nonverbal tasks. Neuropsychologia 38:11–21
Gerhing K, Sitskoorn MM, Gundy CM, Sikkes SAM, Klein M, Potsma TJ, van den Bent MJ, Beute GN, Enting RH, Kappelle AC, Boogerde W, Veninga T, Twijnstra A, Boerman DH, Taphoorn MJB, Aaronson NK (2009) Cognitive rehabilitation in patients with gliomas: a randomized controlled trial. J Clin Oncol 27:3712–3722
Gerhing K, Aaronson NK, Taphoorn MJ, Sitskoorn MM (2010) Interventions for cognitive deficits in patients with a brain tumor: an update. Expert Rev Anticancer Ther 10:1779–1795
Hassler MR, Elandt K, Preusser M, Lehrner J, Binder P, Dieckmann K, Rottenfusser A, Marosi C (2010) Neurocognitive training in patients with high-grade glioma: a pilot study. J Neurooncol 97:109–115
Conflict of interest
The authors declare they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Giovagnoli, A.R. Investigation of cognitive impairments in people with brain tumors. J Neurooncol 108, 277–283 (2012). https://doi.org/10.1007/s11060-012-0815-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11060-012-0815-6